Komori
Medinet (2370) · TargetDropped

Annual Fixed-Cost Reduction of at Least ¥700 Million Through Structural Reform

First written in FY2018-Q2. 3 of 15 entries say "Restated". Latest entry: FY2023.

15entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2018-Q2 – FY2022-Q3SoftenedFY20222018: 220182019: 320192020: 320202021: 320212022: 320222023: 12023
Same theme, other companies
Annualized ¥5.5 Billion Fixed-Cost Reduction Through Structural ReformA theme 8 companies write about · 0 as a headwind · 8 as a tailwind

1 other company's latest entry also says "Dropped".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2023DroppedAnnual report

    「Selling, general and administrative expenses were ¥1,524 million, up 4.3% year on year, due to higher personnel expenses and other factors despite a decrease in R&D expenses」

    The specific previously stated target of “annual fixed-cost reductions of at least ¥700 million” was not restated in this filing, and selling, general and administrative expenses increased 4.3% from the previous fiscal year.
  2. FY2022SoftenedAnnual report

    「This was because, although selling and general administrative expenses decreased as a result of greater cost efficiency and other measures, selling, general and administrative expenses increased to ¥1,461 million, up ¥199 million, or 15.9%, from the previous fiscal year due mainly to higher R&D expenses associated with progress in R&D activities.」

    The specific previous target of “annual fixed-cost reductions of at least ¥700 million” was not restated in the management strategy for the current fiscal year, which referred only to greater cost efficiency. SG&A expenses increased 15.9% year on year due to higher R&D expenses.
  3. FY2022-Q3Continued year-on-year increase in SG&A expensesAnnual report

    「Selling, general and administrative expenses were ¥1,078 million, up 15.7% year on year, due mainly to higher R&D expenses」

    Even after the structural reforms, SG&A expenses increased 15.7% year on year, due mainly to higher R&D expenses.
  4. FY2022-Q2SG&A expenses increased year on yearAnnual report

    「Selling, general and administrative expenses were ¥746 million, up 25.5% year on year, due mainly to higher R&D expenses」

    SG&A expenses, which had been trending downward after the structural reforms, rose 25.5% year on year to ¥746 million during the cumulative second-quarter period, due mainly to higher R&D expenses. Achievement of the annual fixed-cost reduction target of at least ¥700 million was not stated.
  5. FY2021-Q3SG&A expenses increased year on yearAnnual report

    「Selling, general and administrative expenses were ¥932 million, up 4.5% year on year」

    SG&A expenses, which had been trending downward after the structural reforms, increased 4.5% year on year during the cumulative third-quarter period.
  6. FY2021-Q2Slight year-on-year decrease in SG&A expensesAnnual report

    「Selling, general and administrative expenses were ¥595 million, down 1.2% year on year」

    SG&A expenses for the cumulative second-quarter period decreased 1.2% year on year. No new progress toward the previous target of reducing annual fixed costs by at least ¥700 million was specified.
  7. FY2021-Q1SG&A expenses increased year on yearAnnual report

    「Selling, general and administrative expenses were ¥327 million, up 4.2% year on year」

    SG&A expenses, which had been trending downward after the structural reforms, were ¥327 million in the current first quarter, up 4.2% year on year.
  8. FY2020-Q3Continued decrease in SG&A expensesAnnual report

    「Decrease in selling and general administrative expenses through greater efficiency resulting from the thorough implementation and strengthening of business structural reforms and other measures」

    Through the thorough implementation and strengthening of business structural reforms, SG&A expenses were ¥892 million, down 19.9% year on year.
  9. FY2020-Q2Continued decrease in SG&A expensesAnnual report

    「Gross profit was ¥229 million, up 29.8% year on year, while selling, general and administrative expenses were ¥602 million, down 18.9% year on year,」

    Selling, general and administrative expenses, including the effects of structural reform and other measures, decreased 18.9% year on year.
  10. FY2020-Q1SG&A expenses decreased year on yearAnnual report

    「Selling, general and administrative expenses were ¥314 million, down 17.1% year on year,」

    SG&A expenses in the first quarter, including the effects of structural reform and other measures, were ¥314 million, down 17.1% year on year.
  11. FY2019Significant decrease in SG&A expensesAnnual report

    「Selling, general and administrative expenses were ¥1,408 million, down ¥1,622 million, or 53.5%, year on year.」

    SG&A expenses decreased by ¥1,622 million, or 53.5%, year on year as a result of structural reform and other measures. This was reported as an actual reduction in expenses, separately from achievement of the disclosed fixed-cost reduction target itself.
  12. FY2019-Q2RestatedAnnual report

    「Expected fixed costs to decrease by at least ¥700 million annually from the fiscal year ending September 2019 onward.」

    Continued the target of reducing fixed costs by at least ¥700 million annually from the fiscal year ending September 2019 onward through structural reform.
  13. FY2019-Q1RestatedAnnual report

    「Expected fixed costs to decrease by at least ¥700 million annually from the fiscal year ending September 2019 onward.」

    Continued the target of reducing fixed costs by at least ¥700 million annually from the fiscal year ending September 2019 onward through structural reform.
  14. FY2018-Q3RestatedAnnual report

    「Expected fixed costs to decrease by at least ¥700 million annually from the fiscal year ending September 2019 onward.」

    Continued to expect annual fixed-cost reductions of at least ¥700 million from the fiscal year ending September 2019 onward through structural reform.
  15. FY2018-Q2First statedAnnual report

    「From the fiscal year ending September 2019 onward, we expect fixed costs to decline by at least ¥700 million annually.」

    The Company first disclosed a numerical target of reducing fixed costs by at least ¥700 million annually from the fiscal year ending September 2019 onward.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Medinet yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.